1246471-46-4

Usage

Uses

Used in Pharmaceutical Research:
3-Amino-3-methyl-1-pyrrolidino-1-butanone Hydrochloride is used as a research tool for studying the endocannabinoid system, specifically the CB1 receptor's role in the effects of cannabis and other cannabinoids. Its antagonistic properties allow researchers to explore the underlying mechanisms of these effects and their potential therapeutic applications.
Used in Obesity Treatment Research:
In the field of obesity research, 3-Amino-3-methyl-1-pyrrolidino-1-butanone Hydrochloride is used as a potential therapeutic agent to target the CB1 receptor, which is implicated in appetite regulation and energy balance. By blocking this receptor, it may help in managing obesity and related metabolic disorders.
Used in Addiction Treatment Research:
3-Amino-3-methyl-1-pyrrolidino-1-butanone Hydrochloride is used as a potential therapeutic agent for addiction treatment, particularly nicotine addiction. Its ability to modulate the endocannabinoid system may offer new avenues for managing withdrawal symptoms and reducing the rewarding effects of addictive substances.
Used in Neurodegenerative Disease Research:
In the context of neurodegenerative diseases, 3-Amino-3-methyl-1-pyrrolidino-1-butanone Hydrochloride is used as a research tool to investigate the role of the endocannabinoid system in the progression of these diseases. Its antagonistic action on the CB1 receptor may provide insights into potential therapeutic interventions for conditions such as Alzheimer's and Parkinson's disease.
Used in Anti-Cancer Research:
3-Amino-3-methyl-1-pyrrolidino-1-butanone Hydrochloride is used as a potential anti-cancer agent in oncology research. Its effects on the endocannabinoid system may have implications for cancer cell growth, proliferation, and metastasis, offering a novel approach to cancer treatment and management.